MSB
MSB
To the moon
Pinned straw:
Shares in Mesoblast are up ANOTHER 70%-odd today. Shares have seen a 3x gain since it announced last week that the FDA would allow the company to re-submit the Biologics Licence Application for its Ryoncil product due to new clinical data (the company had unsuccessfully submitted for the licence twice before).
I have no insight into the company, the product or the opportunity -- but what a move!
Strong price action, and there seems to be more to go to close that big gap on the chart, but it's cold comfort for the long suffering holders of this stock. How many times has it flattered to deceive? Throw some very dilutionary cap raises on top, and it's a recipe to avoid.
11